(Fort Worth, TX, USA) DFB Pharmaceuticals affiliate Healthpoint, Ltd., a Texas-based market leader in tissue management, dermatology, and surgical products, has signed an agreement with Australia-based Dermal Technologies Pty. Ltd. to distribute OASIS® Wound Matrix in Australia, New Zealand, and a select group of the Pacific islands.
News
Fri, 05/05/2006
|
||
Wed, 04/12/2006
(Fort Worth, Texas) --- Healthpoint announced that as of January 1, 2006 the American Medical Association has released two new Current Procedural Terminology (CPT)® Codes that are relevant to the application of OASIS products. In addition, the Centers for Medicare & Medicaid Services has introduced a new HCPCS Level II code relevant to OASIS products. |
||
|
Tue, 04/04/2006
(Fort Worth, TX) --- HEALTHPOINT, Ltd., a DFB Pharmaceuticals Inc. affiliate company, today announced that it will begin marketing and selling the Collagenase SANTYL® Ointment product line. |
||
Wed, 03/29/2006
(Fort Worth, TX) --- H. Paul Dorman, Chairman and CEO of Fort Worth-based DFB Pharmaceuticals, Inc., has announced that DFB has promoted Duncan Aust, Ph.D. to Senior Vice President of Research and Development, Branded Pharmaceuticals, a newly-created position for DFB. Dr. Aust was most recently Vice President of DPT Research and Development, a DFB affiliate headquartered in San Antonio. |
||
|
Tue, 03/21/2006
(Fort Worth, TX) --- HEALTHPOINT, Ltd., Surgical Division, a DFB Pharmaceuticals, Inc. company, will announce the launch of SURGICEPT™ Waterless Surgical Hand Antiseptic at the Association of periOperative Registered Nurses (AORN) 53rd Congress in Washington, D.C., which begins Tuesday, March 21, 2006. SURGICEPT is the latest member of HEALTHPOINT’s popular, brush free, antisepsis product line. |